Profusa, Inc. Common Stock (PFSA) Stock Price
PFSAStock
$0.93−99.96%52W
Market Cap$563,917.922
P/E—
PEG Ratio—
Div yield—
Beta0.72
PFSA Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-108.57%
Price vs S&P 500 (4W)-50.68%
VGM Score1.60
Industry Peers — Surgical & Medical Instruments(142)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
PFSAProfusa, Inc. Common Stock | — | — | F | — | — | — | — | $0.93 |
| SYKStryker Corporation | C | B | C | 4.4x | 11.8% | 65.3% | 21.3% | $294.66 |
| MMM3M Company | C | D | B | 3.4x | -5.0% | 39.4% | 18.4% | $164.75 |
| BSXBoston Scientific Corp. | C | B | C | 3.1x | 15.2% | 69.5% | 19.8% | $44.39 |
| BDXBecton, Dickinson and Co. | B | D | A | 2.5x | 6.3% | 46.7% | 9.6% | $191.75 |
| MDLNMedline Inc. Class A common stock | C | D | C | 1.6x | — | 26.2% | 6.0% | $35.96 |
| RMDResMed Inc. | C | C | B | 5.9x | 12.1% | 61.1% | 33.4% | $238.97 |
| DXCMDexCom, Inc. | C | B | B | 6.5x | 19.3% | 64.3% | 22.9% | $86.04 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | 8.5x | 7.4% | 36.8% | 20.4% | $384.02 |
| SOLVSolventum Corporation | C | C | B | 1.8x | — | 54.8% | 23.9% | $85.81 |
| BAXBaxter International Inc. | B | D | B | 1.1x | -0.8% | 30.7% | -2.3% | $25.28 |
About Profusa, Inc. Common Stock
Profusa is a clinical-stage medical technology company developing implantable biosensors designed to integrate with the body and continuously transmit clinical-grade health data. The company's technology enables real-time monitoring of biomarkers for various diseases and conditions. Its lead product, the Lumee Oxygen Platform, is available in the European Union and measures tissue oxygen levels for both acute and long-term patient monitoring.